In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.
about
In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 December 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@en
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@nl
type
label
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@en
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@nl
prefLabel
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@en
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@nl
P2093
P2860
P356
P1476
In vivo delivery of nucleic ac ...... c vaccine for type 1 diabetes.
@en
P2093
Massimo Trucco
Nick Giannoukakis
Valentina Di Caro
P2860
P304
P356
10.1900/RDS.2012.9.348
P577
2012-12-28T00:00:00Z